Hypertension and its treatment in postmenopausal women: Baseline data from the Women's Health Initiative

Hypertension

Volumn 36, Issue 5, 2000, Pages 780-789

  Wassertheil Smoller, Sylvia ^a   Anderson, Garnet ^b   Psaty, Bruce M ^c   Black, Henry R ^d   Manson, JoAnn ^e   Wong, Nathan ^f   Francis, Jon ^b   Grimm, Richard ^g   Kotchen, Theodore ^h   Langer, Robert ⁱ   Lasser, Norman ^j  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

more..

Author keywords

Age; Antihypertensive agents; Blood pressure; Hypertension, essential; Women; Women's Health Initiative (WHI)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; COMORBIDITY; DIURETIC THERAPY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL;

EID: 0033679042     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.5.780     Document Type: Article

References (25)

1. The Fifth Report of the Joint National Committee on Detection Evaluation and Treatment of Hypertension: JNC V
2. Five-year findings of the Hypertension Detection and Follow-up Program: Reduction in mortality of persons with high blood pressure including mild hypertension
3. All-cause mortality in the Hypertension, Detection, and Follow-up Program: Findings in the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality
4. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension final results of the Systolic Hypertension in the Elderly Program (SHEP)
5. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
6. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
7. The risk of incident myocardial infarction associated with antihypertensive drug therapies
8. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
9. Design of the Women's Health Initiative Clinical Trial and Observational Study
10. Compendium of physical activities: Classification of energy costs of human activities
11. Trends in the prevalence, awareness, treatment and control of hypertension in the US adult population: Data from the Health and Examination Surveys, 1960-1991
12. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-91
13. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
14. Trends in antihypertensive drug use in the United States: Do the JNC V recommendations affect prescribing?
15. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) for the ALLHAT Research Group
16. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension
17. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Trial (FACET) in patients with hypertension and non-insulin dependent diabetes mellitus
18. Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events
19. New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes
20. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
21. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989
22. Inadequate management of blood pressure in a hypertensive population
23. Effect of anti-hypertensive drug treatment on cardiovascular outcomes in men and women: A meta-analysis of individual patient data from randomized, controlled trials: The INDANA Investigators
24. Health outcomes associated with anti-hypertensive therapies used as first-line agents: A systematic review and meta-analysis